Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL)

Biomedical Papers

Volumn 157, Issue 3, 2013, Pages 239-247

  Nedomova, Radka ^a   Papajik, Tomas ^a   Prochazka, Vit ^a   Indrak, Karel ^a   Jarosova, Marie ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

ArrayCGH; Chromosomal aberrations; Diffuse large B cell lymphoma; Molecular cytogenetics; Prognostic subgroups

Indexed keywords

PROTEIN BCL 6;

ADULT; ARTICLE; CELL TRANSFORMATION; CHROMOSOME ABERRATION; CLASSIFICATION; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; LARGE CELL LYMPHOMA; MALE; MEDIASTINUM TUMOR; PROGNOSIS; PROTO ONCOGENE;

ADULT; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; FEMALE; GENE EXPRESSION PROFILING; GENES, BCL-2; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MEDIASTINAL NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-6;

EID: 84887310356     PISSN: 12138118     EISSN: 18047521     Source Type: Journal    
DOI: 10.5507/bp.2012.085     Document Type: Article

References (40)

1. Lossos IS. Molecular pathogenesis of diffuse large B-cell lymphoma. Journal of Clinical Oncology 2005;23:6351-6357. doi:10.1200/ JC0.2005.05.012
2. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511.
3. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Campo Montserrat E, Lopez-Guillermo A, Ott G, Muller-Hermelink HK, Connors JM, Braziel R, Grogan TM, Fisher RI, Miller TP, LeBlanc M, Chiorazzi M, Zhao H, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Staudt LM. Molecular diagnostic of primary mediastinal B cell lymphoma identifies clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. The Journal of Experimental Medicine 2003;198:851-862.
4. Nogai H, Dorken B, Lenz G. Pathogenesis of non-Hodgkin's lymphoma. Journal of Clinical Oncology 2011;29:1803-1811. doi:10.1200/ JCO.2010.33.3252
5. Levsky JM, Singer RH. Fluorescence in situ hybridization: past, present and future. Journal of Cell Science 2003;116:2833-2838. doi:10.1242/ jcs.00633
6. Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nature Genetics 2005;37:S11-S17. doi:10.1038/ng1569
7. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-821. doi:10.1126/science.1359641
8. Nielaender I, Martin-Subero JI, Wagner F, Martinez-Climent JA, Siebert R. Partial uniparental disomy: a recurrent genetic mechanism alternative to chromosomal deletion in malignant lymphoma. Leukemia 2006;20:904-905. doi:10.1038/sj.leu.2404173
9. Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Gascoyne RD, Connors JM, Grogan TM, Braziel R, Fisher RI, Smeland EB, Kvaloy S, Holte H, Delabie J, Simon R, Powell J, Wilson WH, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Campo E, Rosenwald A, For the Lymphoma/Leukemia Molecular Profiling Project. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Neoplasia 2005;106:3183-3190. doi:10.1182/blood-2005-04-1399
10. Lenz G, Wright GW, Emre NCT, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Wiesenburger DD, Chan WC, Staudt LM. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. The National Academy of Science of the USA 2008;105:13520-13525. doi:10.1073/pnas.0804295105
11. Tibiletti MG, Martin V, Bernasconi B, Del Curto B, Pecciarini L, Uccella S, Pruneri G, Ponzoni M, Mazzucchelli L, Martinelli G, Ferreri AJ, Pinotti G, Assanelli A, Scandurra M, Doglioni C, Zucca E, Capella C, Bertoni F. BCL2, BCL6, MYC, MALT1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome. Human Pathology 2009;40:645-652.
12. Iqbal J, Meyer PN, Smith L, Johnson NA, Vose JM, Greiner TC, Connors J, Staudt LM, Rimsza LM, Jaffe E, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Cook J, Tubbs RR, Gascoyne RD, Armitage JO, Weisenburger DD, Chan W. BCL2 Predicts Survival in Germinal Center B-cell-like Diffuse Large B-Cell Lymphoma Treated with CHOP-like Therapy and Rituximab. Clinical Cancer Research 2011;20:1158-1178.
13. Yoon SO, Jeon YK, Paik JH, Kim WY, Kim YA, Kim JE, Kim CW. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type. Histopathology 2008;53:205-217. do i:10.1111/j.1365-2559.2008.03076
14. Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences 2003;100:9991-9996. doi:10.1073/ pnas.1732008100
15. Niitsu N, Nakamine H, Hagiwara Y, Tanae K, Miura I. The t(1;3) (p34;q27) translocation: a nonrandom BCL6 rearrangement in diffuse large B cell lymphoma. Annals of Hematology 2008;87:151-153. doi:10.1073/pnas.1732008100
16. Jardin F, Ruminy P, Bastard C, Tilly H. The BCL6 proto-oncogene: a leading role during germinal center development and lympho- magenesis. Pathologie Biologie 2007;55:73-83. doi:10.1016/j.pat- bio.2006.04.001
17. Akasaka H, Akasaka T, Kurata M, Ueda C, Shimizu A, Uchiyama T, Ohno H. Molecular anatomy of BCL6 translocation revealed by longdistance polymerase chain reaction-based assays. Cancer Research 2000;60:2335-2341.
18. Tagawa H, Suguro M, Tsuzuki S, Matsuo K, Karnan S, Ohshima K, Okamoto M, Morishima Y, Nakamura S, Seto M. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma. Blood 2005;106:1770-1777. doi:10.1182/ blood-2005-02-0542
19. Thelander EF, Ichimura K, Corcoran M, Barbany G, Nordgren A, Heyman M, Berglund M, Mungall A, Rosenquist R, Collins VP, Grander D, Larsson C, Lagercrantz S. Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia. Leukemia&Lymphoma 2008;49:477-487. doi:10.1080/10428190701817282
20. Stefancikova L, Moulis M, Fabian P, Vasova I, Zedek F, Ravcukova B, Muzik J, Kuglik P, Vranova V, Falkova I, Hrabalkova R, Smardova J. Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma. International Journal of Oncology. 2011;39:1413-1420.
21. Savage KJ. Primary mediastinal large B-cell lymphoma. The Oncologist 2006;11:488-495. doi:10.1634/theoncologist.11-5-488
22. Bishop PC, Wilson WHD, Janik J, Jaffe ES, Elwood PC. CNS involvement in primary mediastinal large B-cell lymphoma. Journal of Clinical Oncology 1999;17:2479-85.
23. Steidl C, Gascoyne D. The molecular pathogenesis of primary mediastinal large B-cell lymphoma. Blood 2011;118:2659-2669. doi:10.1182/ blood-2011-05-326538
24. Joos S, Otano-Joos MI, Ziegler S, Bruderlein S, du Manoir S, Bentz M, Moller P, Lichter P. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996;87:1571-1578.
25. Green MR, Monti S, Rodig SJ, Juszczynski P, Currie T, O'Donnell E, Chapuy B, Takeyama K, Nueberg D, Golub TR, Kutok JL, Shipp MA. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 2010;116:3268-3277. doi:10.1182/ blood-2010-05-282780
26. Montoto S, Davies AJ, Matthews J, Calaminici M, Norton AJ, Amess J, Vinnicombe S, Water R, Rohatiner AZS, Lister TA. Risc and clinical implication of transformation of follicular lymphoma to diffuse large B-cell lymphoma. Journal of Clinical Oncology 2007;27:2426-2433. doi:10.1200/JCO.2006.09.3260
27. Rossi D, Gaidano G. Richter syndrome: molecular insights and clinical perspectives. Hematological Oncology 2009;27:1-10. doi:10.1002/hon.880
28. Scandurra M, Rossi D, Daembrogi C, Rancoita PMV, Chigrinova E, Mian M, Cerri M, Rasi S, Sozzi E, Forconi F, Ponzoni M, Moreno SM, Piris MA, Inghirami G, Zucca E, Gattei V, Rinaldi A, Kwee I, Gaidano Bertoni F. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas. Hematological Oncology 2010;28:62-7. doi:10.1002/hon.932
29. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ. A microRNA polycistron as a potential human oncogene. Nature 2005;435:828-833. doi:10.1038/nature03552
30. Chang CC, Ye BH, Chaganti RS, Dalla-Favera R. BCL-6, a POZ/zinc- finger protein, is a sequence-specific transcriptional repressor. Proceedings of the National Academy of Sciences of the United States of America 1996;93:6947-6952.
31. Savage KJ, Johnson NA, Ben-Neriah S, Connors JM, Sehn, LH, Farinha P, Horsman DE, Gascoyne RD. MYC gene rearrangements are associated with poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood 2009;114:3533-3537. doi:10.1182/blood-2009-05-220095
32. Barrans S, Crouch S, Smith A, Turner K, Owen R, Patmore R, Roman E, Jack A. Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of Rituximab. Journal of Clinical Oncology 2010;28:3360-3365. doi:10.1200/ JCO.2009.26.3947
33. Rao PH, Houldsworth J, Domina K, Parsa NZ, Cigudosa JC, Louine DC, Popplewell L, Octit K, Jhanwar C, Chaganti RS. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 1998;92:234-240.
34. Testoni M, Kwee I, Greitner TC, Montes-Moreno S, Vose J, Chan WC, Chiappella A, Baldini L, Ferreri AJM, Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP. British Journal of Haematology 2011;155:268-280.
35. Aukema S, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ, Kluin PM. Double-hit B-cell lymphomas. Blood 2011;117:2319-2331. doi:10.1182/blood-2010-09-297879
36. Barrans SL, Evans PA, O'Connors SJ, Kendal SJ, Owen RG, Haynes AP, Morgan GJ, Jack AS. The t(14;18) is associated with germinal center- derived diffuse large B-cell lymphoma and is a strong predictor of outcome. Clinical Cancer Research 2003;9:2133-2139.
37. Shustik J, Han G, Farinha P, Johnson NA, Neriah SB, Connors JM, Sehn LH, Horsman DE, Gascoyne RD, Steidl C. Correlation between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP. Haematologica 2010;95:96-101.
38. Dunleavy K, Czuczman MS, Dave SS, Wright G, Grant N, Shovlin M, Jaffe JE, Janik JE, Staudt LM, Wilson WH. Differential efficacy of bort- ezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood 2009;113:6069-6076. doi:10.1182/ blood-2009-01-199679
39. Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, Wells VA, Grunt A, Mesina M, Elliot O, Chan J, Bhagat G, Chadburn A, Gaidano G, Mullighan CG, Ramadan R, Dalla-Favera R. Analysis of the coding genome of diffuse large B-cell lymphoma. Nature Genetics 2011;43:830-839. doi:10.1038/ng.892
40. Wilson WH, Hernandez-Ilizaliturri FJ, Dunleavy K, Little RF, O'Connor OA. Novel disease targets and management approaches for diffuse large B-cell lymphoma. Leukemia&Lymphoma 2010;51:1-10. doi:1 0.3109/10428194.2010.500045